ZBiotics

About ZBiotics

ZBiotics is a biotechnology company focused on creating genetically engineered probiotics to improve daily life. Their mission is to provide access to the power of biotechnology through GMO probiotics, aiming to enhance health and well-being while changing the conversation around biotech.

Products & Services

Pre-Alcohol:A probiotic drink that breaks down acetaldehyde, a toxic byproduct of alcohol, to help mitigate rough mornings after drinking.

Sugar-to-Fiber:A drink mix that converts dietary sugar into fiber using the enzyme levansucrase, supporting microbiome health.

Specialties

Genetically Engineered Probiotics Microbiome Health Alcohol Byproduct Breakdown Dietary Sugar Conversion

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 12000000 MR: - FA: $12 million FAN: 12000000	D: 2024-08-27 FD: 2024-08-27	5 investors

Series A Latest

2024-08-27

$12.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Z

Zack Abbott

CEO, Co-founder

S

Stephen Lamb

COO, Co-founder

K

Kat Townsend

Chief of Marketing

A

Anna Lamb

Senior Manager, Growth Marketing and Innovation

M

Michael Mullaney

VP of Supply Chain

N

Nicole Shahin

Senior Manager of Customer Experience

View 27 more team members with Pro

Unlock Full Team Directory

Recent News

ZBiotics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised